The Effect of Dexmedetomidine, Magnesium Sulfate or Midazolam as Adjuvant to Bupivacaine in Ultrasound Guided Supraclavicular Brachial Plexus Block
DOI:
https://doi.org/10.48047/a7gg2y59Keywords:
Bupivacaine; Dexmedetomidine; Magnesium sulfate; Midazolam; Supraclavicular brachial plexus block; Ultrasound-guided regional anesthesiAbstract
Abstract: Background: Different adjuvant have been used to improve the quality of regional anesthesia.
The aim of the study: It is evaluation and comparing the effects of dexmedetomidine, magnesium sulfate and midazolam when added as adjuvant to bupivacaine on the quality of US-guided supraclavicular brachial plexus block.
Patients and methods: This prospective, randomized controlled trial was conducted on 100 patients undergoing upper limb surgery under US-guided supraclavicular brachial plexus block. These patients were randomized into 4 equal groups. 15 ml of 0.5% bupivacaine plus each of 5ml normal saline, 1µg/kg dexmedetomidine, 3 mg/kg of 10% magnesium sulfate and 50µg/kg of midazolam were used in the control (B/S) group, dexmedetomidine (B/D) group, magnesium sulfate (B/MgS) group and midazolam (B/M) group, respectively. Onset and duration of sensory and motor blocks, time to first analgesic request, total postoperative analgesic consumption, hemodynamic changes, and the associated side effects were recorded.
Results: The block onset times, intraoperative analgesic potency, duration of postoperative analgesia and rates of the associated side effects in B/D, B/MgS, and B/M groups were significantly better than in B/S (Control) group (P <0.001) and in B/D group they were significantly better than in B/MgS and B/M groups (P =0.042) and in B/MgS group they were significantly better than that in B/M group.
Conclusion: Addition of Dexmedetomidine, Magnesium sulfate and midazolam as adjuvant to bupivacaine are efficient in improving the characteristics of supraclavicular brachial plexus block but Dexmedetomidine is the most efficient one that followed by Magnesium sulfate and then by midazolam.
Downloads
References
Kusre S, McEwen A, Matthew G. Ultrasound-guided supraclavicular brachial plexus block. Reg Anaesth Tutorial 2018;(384).
Lewis SR, Price A, Walker KJ, McGrattan K, Smith AF. Ultrasound guidance for upper and lower limb blocks. Cochrane Database Syst Rev 2015;(9):CD006459. https://doi.org/10.1002/14651858.CD006459.pub3
Hari K, Rajagopal P, Binu PS. Comparison between 0.5% bupivacaine–dexamethasone combination and 0.5% bupivacaine–clonidine combination in brachial plexus blocks by supraclavicular approach. J Evid Based Med Healthc 2015;2(15):3016–24.
Simon MAM, Gielen MJM, Alberink N. Intravenous regional anesthesia with 0.5% articaine, 0.5% lidocaine, or 0.5% prilocaine. Reg Anesth 1997;22:29–34.
Solak M, Akturk G, Erciyes N. The addition of sodium bicarbonate to prilocaine solution during IV regional anesthesia. Acta Anaesthesiol Scand 1991;35:572–4.
Hamada MH, Ibrahim WM, Ashiry MA. Dexmedetomidine and dexamethasone as adjuvant to bupivacaine in ultrasound-guided supraclavicular brachial plexus block in upper limb surgeries. Egypt J Hosp Med 2019;75(6):3060–9.
Choyce A, Peng P. A systematic review of adjuncts for intravenous regional anesthesia for surgical procedures. Can J Anaesth 2002;49(1):32–45.
Laiq N, Khan MN, Arif M. Midazolam with bupivacaine for improving analgesia quality in brachial plexus block for upper limb surgeries. J Coll Physicians Surg Pak 2008;18(11):674–8.
Mukherjee K, Das A, Basunia SR. Evaluation of magnesium as an adjuvant in ropivacaine-induced supraclavicular brachial plexus block: a prospective, double-blinded randomized controlled study. J Res Pharm Pract 2014;3:123–9.
Attri JP, Kataria AP, Garg S, Sharma A. Efficacy of nalbuphine and magnesium sulfate with ropivacaine for quality of supraclavicular brachial plexus block and postoperative analgesia. Int J Sci 2019;6(11):32–7.
Bharti N, Sardana DK, Bala I. The analgesic efficacy of dexmedetomidine as adjunct to local anesthetics in supraclavicular brachial plexus block: a randomized controlled trial. Surv Anesthesiol 2016;60:218–9.
Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone–alphadolone. BMJ 1974;2:656–9.
Esmaoglu A, Yegenoglu F, Akin A, Turk CY. Dexmedetomidine added to levobupivacaine prolongs axillary brachial plexus block. Anesth Analg 2010;111(6):1548–51. doi:10.1213/ANE.0b013e3181fa3095.
Ammar AS, Mahmoud KM. Ultrasound-guided single injection infraclavicular brachial plexus block using bupivacaine alone or combined with dexmedetomidine for pain control in upper limb surgery: a prospective randomized controlled trial. Saudi J Anaesth 2012;6:109–14. doi:10.4103/1658-354X.97021.
Das A, Majumdar S, Halder S, Chattopadhyay S, Pal S, Kundu R, et al. Effect of dexmedetomidine as adjuvant in ropivacaine-induced supraclavicular brachial plexus block: a prospective, double-blinded randomized controlled study. Saudi J Anaesth 2014;8(Suppl 1):S72–7. doi:10.4103/1658-354X.144082.
Hassan M, Abaza KA, Fawzy E, Kamel A. Magnesium sulfate versus dexmedetomidine as additive to lidocaine and bupivacaine in ultrasound-guided supraclavicular brachial plexus block. Zagazig Univ Med J 2020;1066–77. doi:10.21608/zumj.2019.13591.1253.
Lee AR, Yi HW, Chung IS, Ko JS, Ahn HJ, Gwak MS, et al. Magnesium added to bupivacaine prolongs duration of analgesia after interscalene nerve block. Can J Anaesth 2012;59:21–7. doi:10.1007/s12630-011-9604-5.
Mukherjee K, Das A, Basunia SR, Dutta S, Mandal P, Mukherjee A, et al. Evaluation of magnesium as adjuvant in ropivacaine-induced supraclavicular brachial plexus block: a prospective, double-blinded randomized controlled study. J Res Pharm Pract 2014;3:123–9. doi:10.4103/2279-042X.145387.
Haghighi M, Soleymanha M, Sedighinejad A, Mirbolook A, Naderi Nabi B, Rahmati M, et al. Effect of magnesium sulfate on motor and sensory axillary plexus blockade. Anesth Pain Med 2015;5:e21943. doi:10.5812/aapm.21943.
Abu Elyazed MM, Mogahed MM. Comparison of magnesium sulfate and dexmedetomidine as adjuvant to 0.5% ropivacaine in infraclavicular brachial plexus block. Anesth Essays Res 2018;12(1):109–15. doi:10.4103/aer.AER_70_17.
Jie Z, Qi C, Cong Y, Ju Z, Bin Y. Use of magnesium sulfate and peripheral nerve blocks: updated meta-analysis and systematic review. Clin J Pain 2021;37(8):629–37. doi:10.1097/AJP.0000000000000944.
Senapathi ATGA, Sucandra IMAK. Evaluating efficacy of MgSO4 as adjuvant to 0.5% bupivacaine in supraclavicular–intercostobrachial nerve blocks for upper extremity hemodialysis access surgery. SEEJPH 2025;3437–46. doi:10.70135/seejph.vi.4548.
Bassiony MA, Ghaly SI, Selima WZ, Mostafa FA. Magnesium sulfate with local anesthetics versus local anesthetics alone in supraclavicular brachial plexus block. QJM 2020;113(Suppl 1):hcaa039-015.
Gulec S, Buyukkidan B, Oral N, Ozcan N, Tanriverdi B. Comparison of caudal bupivacaine, bupivacaine-morphine and bupivacaine-midazolam mixtures for postoperative analgesia in children. Eur J Anaesthesiol 1998;15:161–5.
Batra YK, Jain K, Chari P, Dhillon MS, Shaheen B, Reddy GM. Addition of intrathecal midazolam to bupivacaine produces better postoperative analgesia without prolonging recovery. Int J Clin Pharmacol Ther 1999;37:519–23.
Mahajan R, Batra YK, Grover VK, Kajal J. Comparative study of caudal bupivacaine and midazolam-bupivacaine mixture for postoperative analgesia in children. Int J Clin Pharmacol Ther 2001;39:116–20.
Jarbo K, Batra YK, Panda NP. Brachial plexus block with midazolam and bupivacaine improves analgesia. Can J Anaesth 2005;52:822–6. doi:10.1007/BF03021776.
Moharam SA, Basuoni AS, Abd-Elhafez AA, Ibrahim AS. Evaluation of midazolam as adjuvant to bupivacaine in supraclavicular brachial plexus block. Tanta Med J 2017;45(2):99–103. doi:10.4103/tmj.tmj_17_17.
Mohamed AZE, Genidy MM. Magnesium sulphate versus dexmedetomidine as adjuvant to local anesthetic mixture in peribulbar anesthesia. Egypt J Anaesth 2017;33(4):375–80.
Shukla U, Singh D, Yadav JBS, Azad MS. Dexmedetomidine and magnesium sulfate as adjuvant to 0.5% ropivacaine in supraclavicular brachial plexus block: a comparative evaluation. Anesth Essays Res 2020;14(4):572–7. doi:10.4103/aer.AER_28_21.
Youssef AAN, Diab DG, Abdel Mohymen HA, Abd Allah MYY. Dexmedetomidine versus midazolam as local anesthetic adjuvants to bupivacaine in ultrasound-guided supraclavicular brachial plexus block. Int J Med Arts 2023;5(10):3701–9. doi:10.21608/IJMA.2023.224567.1744.
Usha S, Dheer S, Singh YJB, Singh A. Dexmedetomidine and magnesium sulfate as adjuvant to 0.5% ropivacaine in supraclavicular brachial plexus block: a comparative evaluation. Anesth Essays Res 2020;14(4):572–7. doi:10.4103/aer.AER_28_21.
Wu J, Chen G, Quan X, Shu H, Duan G, Shu B, et al. Combination of different local anesthetic adjuvants for supraclavicular brachial plexus block after arthroscopic shoulder surgery: a prospective randomized controlled trial. BMC Musculoskelet Disord 2024;25(1):844. doi:10.1186/s12891-024-07918-3.
Rao LN, Jeyalakshmi V, Nagaraju M, Anitha S. Effect of magnesium sulfate as adjuvant to 0.5% bupivacaine on motor and sensory supraclavicular brachial plexus blockade. Int J Basic Clin Pharmacol 2017;4(2):317–21.
Talke P, Lobo E, Brown R. Systemically administered alpha2-agonist-induced peripheral vasoconstriction in humans. Anesthesiology 2003;99:65–70.
Guo TZ, Jiang JY, Buttermann AE, Maze M. Dexmedetomidine injection into the locus ceruleus produces antinociception. Anesthesiology 1996;84:873–81.
Kosugi T, Mizuta K, Fujita T, Nakashima M, Kumamoto E. High concentrations of dexmedetomidine inhibit compound action potentials in frog sciatic nerves without alpha(2) adrenoceptor activation. Br J Pharmacol 2010;160:1662–7.
Cairns BE, Sessle BJ, Hu JW. Activation of peripheral GABAA receptors inhibits temporomandibular joint-evoked jaw muscle activity. J Neurophysiol 1999;81:1966–9.
Faull RLM, Villiger JW. Benzodiazepine receptors in the human spinal cord: a detailed anatomical and pharmacological study. Neuroscience 1986;17:791–9.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
